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A synthetic hydroxypropenone inhibits nitric oxide, prostaglandin E2, and 
proinflammatory cytokine synthesis 
 
ABSTRACT 
HMP [3-(2-hydroxyphenyl)-1-(5-methyl-furan-2-y-l) propenone] was evaluated for its ability 
to inhibit the synthesis of major proinflammatory mediators and cytokines in interferon-
gamma (IFN-gamma)- and lipopolysaccharide (LPS)-induced RAW 264.7 cells and phorbol 
myristate acetate (PMA)-differentiated/LPS-induced U937 cells. HMP suppressed the 
production of nitric oxide (NO) with significant inhibitory effects at doses as low as 0.78 
microM (P < 0.05). Prostaglandin E2 (PGE2) secretion was also inhibited at doses of 12.5 
microM and above (P < 0.01). The secretion of both TNF-alpha and IL-6 were only inhibited 
at the highest dose used (25 microM; P < 0.001). IL-1beta secretion was also inhibited from 
12.5 microM onwards (P < 0.01). This inhibition was demonstrated to be caused by down-
regulation of inducible enzymes, inducible nitric oxide synthase (iNOS), and 
cyclooxygenase-2 (COX-2), without direct effect upon iNOS or COX-2 enzyme activity. 
HMP only inhibited iNOS (P < 0.001) and IL-1beta (P < 0.05) gene expression at the highest 
tested concentration. HMP did not affect the secretion of chemokines IL-8 and monocyte 
chemotactic protein-1 (MCP-1) and the anti-inflammatory cytokine IL-10. The most striking 
effect of HMP was its NO inhibitory activity and therefore we conclude that HMP is a 
selective inhibitor of iNOS. 
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